JP2003146899A - Skin-improving agent - Google Patents
Skin-improving agentInfo
- Publication number
- JP2003146899A JP2003146899A JP2001345277A JP2001345277A JP2003146899A JP 2003146899 A JP2003146899 A JP 2003146899A JP 2001345277 A JP2001345277 A JP 2001345277A JP 2001345277 A JP2001345277 A JP 2001345277A JP 2003146899 A JP2003146899 A JP 2003146899A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- pine bark
- bark extract
- improving agent
- pine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000020741 pine bark extract Nutrition 0.000 claims abstract description 46
- 229940106587 pine bark extract Drugs 0.000 claims abstract description 44
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 27
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 27
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000005487 catechin Nutrition 0.000 claims abstract description 20
- 235000013402 health food Nutrition 0.000 claims abstract description 11
- 229960005070 ascorbic acid Drugs 0.000 claims abstract description 9
- 235000010323 ascorbic acid Nutrition 0.000 claims abstract description 7
- 239000011668 ascorbic acid Substances 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 3
- 150000001765 catechin Chemical class 0.000 claims description 17
- JPFCOVZKLAXXOE-XBNSMERZSA-N (3r)-2-(3,5-dihydroxy-4-methoxyphenyl)-8-[(2r,3r,4r)-3,5,7-trihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2h-chromen-4-yl]-3,4-dihydro-2h-chromene-3,5,7-triol Chemical compound C1=C(O)C(OC)=C(O)C=C1C1[C@H](O)CC(C(O)=CC(O)=C2[C@H]3C4=C(O)C=C(O)C=C4O[C@@H]([C@@H]3O)C=3C=CC(O)=CC=3)=C2O1 JPFCOVZKLAXXOE-XBNSMERZSA-N 0.000 claims description 3
- 229920001991 Proanthocyanidin Polymers 0.000 claims description 3
- 229920002770 condensed tannin Polymers 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 12
- 102000008186 Collagen Human genes 0.000 abstract description 8
- 108010035532 Collagen Proteins 0.000 abstract description 8
- 229920001436 collagen Polymers 0.000 abstract description 8
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 abstract description 7
- 235000013305 food Nutrition 0.000 abstract description 5
- 229950001002 cianidanol Drugs 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 31
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- 238000000605 extraction Methods 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 241000018646 Pinus brutia Species 0.000 description 10
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 9
- 235000011613 Pinus brutia Nutrition 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000012530 fluid Substances 0.000 description 8
- 238000006116 polymerization reaction Methods 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 238000000194 supercritical-fluid extraction Methods 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 5
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 5
- 235000010204 pine bark Nutrition 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- GQPLMRYTRLFLPF-UHFFFAOYSA-N Nitrous Oxide Chemical compound [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- 230000005494 condensation Effects 0.000 description 4
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 4
- 229960002591 hydroxyproline Drugs 0.000 description 4
- 239000003960 organic solvent Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- XMOCLSLCDHWDHP-SWLSCSKDSA-N (+)-Epigallocatechin Natural products C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-SWLSCSKDSA-N 0.000 description 3
- 229930013915 (+)-catechin Natural products 0.000 description 3
- 235000007219 (+)-catechin Nutrition 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 3
- 240000007320 Pinus strobus Species 0.000 description 3
- 235000008578 Pinus strobus Nutrition 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- XIMADJWJJOMVID-UHFFFAOYSA-N 2-phenyl-3,4-dihydro-2h-chromene-3,4-diol Chemical compound OC1C(O)C2=CC=CC=C2OC1C1=CC=CC=C1 XIMADJWJJOMVID-UHFFFAOYSA-N 0.000 description 2
- 235000005638 Austrian pine Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920002261 Corn starch Polymers 0.000 description 2
- 240000006055 Dacrydium cupressinum Species 0.000 description 2
- 235000018782 Dacrydium cupressinum Nutrition 0.000 description 2
- 239000004278 EU approved seasoning Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 235000005205 Pinus Nutrition 0.000 description 2
- 241000218602 Pinus <genus> Species 0.000 description 2
- 235000008565 Pinus banksiana Nutrition 0.000 description 2
- 235000013264 Pinus jeffreyi Nutrition 0.000 description 2
- 235000013697 Pinus resinosa Nutrition 0.000 description 2
- 235000008585 Pinus thunbergii Nutrition 0.000 description 2
- 235000014030 Podocarpus spicatus Nutrition 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- -1 aliphatic alcohols Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000008120 corn starch Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000011194 food seasoning agent Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 235000017985 rocky mountain lodgepole pine Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229930013884 (+)-gallocatechin Natural products 0.000 description 1
- 235000007243 (+)-gallocatechin Nutrition 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- 229930013783 (-)-epicatechin Natural products 0.000 description 1
- 235000007355 (-)-epicatechin Nutrition 0.000 description 1
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 1
- LVGUZGTVOIAKKC-UHFFFAOYSA-N 1,1,1,2-tetrafluoroethane Chemical compound FCC(F)(F)F LVGUZGTVOIAKKC-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- LPXQRXLUHJKZIE-UHFFFAOYSA-N 8-azaguanine Chemical compound NC1=NC(O)=C2NN=NC2=N1 LPXQRXLUHJKZIE-UHFFFAOYSA-N 0.000 description 1
- 208000035285 Allergic Seasonal Rhinitis Diseases 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 235000018783 Dacrycarpus dacrydioides Nutrition 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 1
- 239000004129 EU approved improving agent Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- OEIJRRGCTVHYTH-UHFFFAOYSA-N Favan-3-ol Chemical compound OC1CC2=CC=CC=C2OC1C1=CC=CC=C1 OEIJRRGCTVHYTH-UHFFFAOYSA-N 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 101000879758 Homo sapiens Sjoegren syndrome nuclear autoantigen 1 Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000218652 Larix Species 0.000 description 1
- 235000005590 Larix decidua Nutrition 0.000 description 1
- 241001133829 Latania Species 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- 235000016357 Mirtillo rosso Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000000405 Pinus densiflora Nutrition 0.000 description 1
- 240000008670 Pinus densiflora Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241001495449 Robinia pseudoacacia Species 0.000 description 1
- 102100037330 Sjoegren syndrome nuclear autoantigen 1 Human genes 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical group [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- 244000077923 Vaccinium vitis idaea Species 0.000 description 1
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- VDQQXEISLMTGAB-UHFFFAOYSA-N chloramine T Chemical compound [Na+].CC1=CC=C(S(=O)(=O)[N-]Cl)C=C1 VDQQXEISLMTGAB-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000004807 desolvation Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 210000003278 egg shell Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 235000021112 essential micronutrients Nutrition 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930182497 flavan-3-ol Natural products 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940087559 grape seed Drugs 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000001272 nitrous oxide Substances 0.000 description 1
- 235000013842 nitrous oxide Nutrition 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000007395 thrombosis prophylaxis Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 150000003700 vitamin C derivatives Chemical class 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、松樹皮抽出物を含
有することを特徴とする、皮膚改善剤およびそれを含有
する健康食品に関する。TECHNICAL FIELD The present invention relates to a skin improving agent, which contains a pine bark extract, and a health food containing the same.
【0002】[0002]
【従来の技術】アスコルビン酸(以下、ビタミンCとい
うこともある)は人にとって必要不可欠な微量栄養素で
あり、免疫賦活作用、血中コレステロールの低下作用な
どのほかに、美白や美肌作用などの皮膚改善作用を有す
ることが報告されている。しかしながら、このビタミン
Cは、水溶性ビタミンであり、体内で長時間維持するこ
とができず、通常、摂取しても2〜3時間で尿中に排出
されてしまう。このため、体に必要なビタミンCは、一
日に摂取するビタミンCの量を数回に分けて摂るなどの
工夫が必要とされている。2. Description of the Related Art Ascorbic acid (hereinafter sometimes referred to as vitamin C) is an essential micronutrient for humans. In addition to its immunostimulatory action and blood cholesterol lowering action, it also has a whitening and skin-reducing action on the skin. It has been reported to have an improving effect. However, this vitamin C is a water-soluble vitamin, which cannot be maintained in the body for a long time, and is normally excreted in urine within 2 to 3 hours even if ingested. For this reason, the amount of vitamin C required for the body needs to be devised such that the amount of vitamin C to be ingested in one day is divided into several times.
【0003】従って、アスコルビン酸(ビタミンC)の
皮膚改善作用を十分に発揮させるためには、一定時間に
絶えず飲みつづけることが必要となるため、ビタミンC
を単独で用いる皮膚改善剤はあまり効果があるとはいえ
ず、新たな皮膚改善作用を有する物質およびその物質を
含む食品が求められている。Therefore, in order to fully exert the skin-improving action of ascorbic acid (vitamin C), it is necessary to continue drinking for a certain period of time.
It cannot be said that the skin-improving agent used alone is very effective, and there is a demand for a substance having a new skin-improving action and a food containing the substance.
【0004】[0004]
【発明が解決しようとする課題】本発明は、上記状況に
鑑み、なされたものであり、本発明の目的は、新規の皮
膚改善剤およびそれを含有する健康食品を提供すること
にある。The present invention has been made in view of the above circumstances, and an object of the present invention is to provide a novel skin improving agent and a health food containing the same.
【0005】[0005]
【課題を解決するための手段】本発明者らは、皮膚質を
改善できる天然素材の探索を行った結果、松樹皮抽出物
を用いることにより、皮膚質が改善されることを見出し
て、本発明の完成に至った。Means for Solving the Problems As a result of a search for a natural material capable of improving the skin quality, the present inventors have found that the use of a pine bark extract improves the skin quality. The invention was completed.
【0006】上記課題は、松樹皮抽出物を含有すること
を特徴とする皮膚改善剤およびこの皮膚改善剤を有する
食品により解決される。すなわち、本発明は、松樹皮抽
出物を含有することを特徴とする、皮膚改善剤を提供す
る。The above-mentioned problems can be solved by a skin improving agent characterized by containing a pine bark extract and a food containing the skin improving agent. That is, the present invention provides a skin improving agent comprising a pine bark extract.
【0007】好ましい実施態様においては、前記松樹皮
抽出物が、OPC(oligomeric proanthocyanidin)を
20重量%以上含有する松樹皮抽出物である。In a preferred embodiment, the pine bark extract is a pine bark extract containing 20% by weight or more of OPC (oligomeric proanthocyanidin).
【0008】さらに好ましい実施態様においては、前記
松樹皮抽出物が、20重量%以上のOPCを含有するこ
とに加えて、カテキン(catechin)類を5.0重量%以
上含有する松樹皮抽出物である。[0008] In a further preferred embodiment, the pine bark extract is a pine bark extract containing not less than 20% by weight of OPC and 5.0% by weight or more of catechins. is there.
【0009】また、別の実施態様においては、本発明の
皮膚改善剤は、アスコルビン酸またはその塩を含有す
る。[0009] In another embodiment, the skin improving agent of the present invention contains ascorbic acid or a salt thereof.
【0010】本発明は、また、前記いずれかの皮膚改善
剤を含有する健康食品を提供する。The present invention also provides a health food containing any of the aforementioned skin improving agents.
【0011】本発明の松樹皮抽出物を含有する皮膚改善
剤およびこの皮膚改善剤を含有する健康食品を摂取する
ことにより、日常的に皮膚が改善される。The skin is routinely improved by ingesting the skin improving agent containing the pine bark extract of the present invention and the health food containing the skin improving agent.
【0012】[0012]
【発明の実施の形態】本発明の皮膚改善剤は、松樹皮抽
出物を含有することを特徴とする。松樹皮抽出物として
は、フランス海岸松(Pinus Martima)、カラマツ、ク
ロマツ、アカマツ、ヒメコマツ、ゴヨウマツ、チョウセ
ンマツ、ハイマツ、リュウキュウマツ、ウツクシマツ、
ダイオウマツ、シロマツ、カナダのケベック地方のアネ
ダ等の樹皮抽出物が好ましく用いられる。中でも、フラ
ンス海岸松(Pinus Martima)の樹皮抽出物が好ましく
用いられる。BEST MODE FOR CARRYING OUT THE INVENTION The skin improving agent of the present invention is characterized by containing a pine bark extract. Pine bark extracts include French coastal pine (Pinus Martima), larch, black pine, red pine, red pine, black pine, pine pine, high pine, Ryukyu pine, Japanese pine,
Bark extracts such as rhubarb, white pine, and aneda from Quebec, Canada are preferably used. Of these, bark extract of French coastal pine (Pinus Martima) is preferably used.
【0013】フランス海岸松は、南仏の大西洋沿岸の一
部に生育している海洋性松をいう。このフランス海岸松
の樹皮は、フラボノイド類であるプロアントシアニジン
(proanthocyanidin)を主要成分として含有する他に、
有機酸並びにその他の生理活性成分等を含有している。
この主要成分であるプロアントシアニジンには、活性酸
素を除去する強い抗酸化作用があることが知られてい
る。The French coastal pine is a marine pine that grows on a part of the Atlantic coast of southern France. The bark of this French coastal pine tree contains proanthocyanidin, which is a flavonoid, as a main component,
It contains organic acids and other physiologically active ingredients.
It is known that proanthocyanidin, which is this main component, has a strong antioxidant action of removing active oxygen.
【0014】松樹皮抽出物は、上記松の樹皮を水または
有機溶媒で抽出して得られる。水を用いる場合には温
水、または熱水が用いられる。抽出に用いる有機溶媒と
しては、メタノール、エタノール、1−プロパノール、
2−プロパノール、1−ブタノール、2−ブタノール、
ブタン、アセトン、ヘキサン、シクロヘキサン、プロピ
レングリコール、含水エタノール、含水プロピレングリ
コール、エチルメチルケトン、グリセリン、酢酸メチ
ル、酢酸エチル、ジエチルエーテル、ジクロロメタン、
食用油脂、1,1,1,2−テトラフルオロエタン、
1,1,2−トリクロロエテン等の食品あるいは薬剤の
製造に許容される有機溶媒が好ましく用いられる。これ
らの水、有機溶媒は単独で用いてもよいし、組合わせて
用いてもよい。特に、熱水、含水エタノール、含水プロ
ピレングリコール等が好ましく用いられる。The pine bark extract is obtained by extracting the bark of the pine tree with water or an organic solvent. When water is used, hot water or hot water is used. As the organic solvent used for extraction, methanol, ethanol, 1-propanol,
2-propanol, 1-butanol, 2-butanol,
Butane, acetone, hexane, cyclohexane, propylene glycol, hydrous ethanol, hydrous propylene glycol, ethyl methyl ketone, glycerin, methyl acetate, ethyl acetate, diethyl ether, dichloromethane,
Edible oil and fat, 1,1,1,2-tetrafluoroethane,
Organic solvents acceptable for the production of foods or drugs such as 1,1,2-trichloroethene are preferably used. These water and organic solvents may be used alone or in combination. In particular, hot water, hydrous ethanol, hydrous propylene glycol and the like are preferably used.
【0015】松樹皮からの抽出方法は特に制限はない
が、例えば、加温抽出法、超臨界流体抽出法などが用い
られる。The extraction method from pine bark is not particularly limited, but for example, a heating extraction method, a supercritical fluid extraction method or the like is used.
【0016】超臨界流体抽出法とは、物質の気液の臨界
点(臨界温度、臨界圧力)を超えた状態の流体である超
臨界流体を用いて抽出を行う方法である。超臨界流体と
しては、二酸化炭素、エチレン、プロパン、亜酸化窒素
(笑気ガス)等が用いられるが、二酸化炭素が好ましく
用いられる。The supercritical fluid extraction method is a method of performing extraction using a supercritical fluid which is a fluid in a state of exceeding the gas-liquid critical point (critical temperature, critical pressure) of a substance. Carbon dioxide, ethylene, propane, nitrous oxide (laughing gas) and the like are used as the supercritical fluid, but carbon dioxide is preferably used.
【0017】超臨界流体抽出法では、目的成分を超臨界
流体によって抽出する抽出工程と、目的成分と超臨界流
体を分離する分離工程とを行う。分離工程では、圧力変
化による抽出分離、温度変化による抽出分離、吸着剤・
吸収剤を用いた抽出分離のいずれを行ってもよい。In the supercritical fluid extraction method, an extraction step of extracting the target component with the supercritical fluid and a separation step of separating the target component and the supercritical fluid are performed. In the separation process, extraction separation due to pressure change, extraction separation due to temperature change, adsorbent
Any of extraction and separation using an absorbent may be performed.
【0018】また、エントレーナー添加法による超臨界
流体抽出を行ってもよい。この方法は、抽出流体に、例
えば、エタノール、プロパノール、n−ヘキサン、アセ
トン、トルエン、その他の脂肪族低級アルコール類、脂
肪族炭化水素類、芳香族炭化水素類、ケトン類を2〜2
0W/V%程度添加し、この流体を用いて超臨界流体抽
出を行うことによって、OPC、カテキン類などの目的
とする抽出物の抽出溶媒に対する溶解度を飛躍的に上昇
させる、あるいは分離の選択性を増強させる方法であ
り、効率的な松樹皮抽出物を得る方法である。Supercritical fluid extraction may be carried out by the entrainer addition method. According to this method, for example, ethanol, propanol, n-hexane, acetone, toluene, other lower aliphatic alcohols, aliphatic hydrocarbons, aromatic hydrocarbons, and ketones are added to the extraction fluid in an amount of 2 to 2.
By adding about 0 W / V% and performing supercritical fluid extraction using this fluid, the solubility of the target extract such as OPC and catechins in the extraction solvent is dramatically increased, or the selectivity of separation is increased. And a method for obtaining an efficient pine bark extract.
【0019】超臨界流体抽出法は、比較的低い温度で操
作できるため、高温で変質・分解する物質にも適用でき
るという利点、抽出流体が残留しないという利点、溶媒
の循環利用が可能でるため、脱溶媒工程などが省略で
き、工程がシンプルになるという利点がある。Since the supercritical fluid extraction method can be operated at a relatively low temperature, it can be applied to substances that are altered or decomposed at high temperatures, the advantage that no extraction fluid remains, and the solvent can be circulated and used. There is an advantage that the desolvation step and the like can be omitted and the step is simplified.
【0020】松樹皮からの抽出は、上記の抽出法以外
に、液体二酸化炭素回分法、液体二酸化炭素還流法、超
臨界二酸化炭素還流法等により行ってもよい。Extraction from pine bark may be performed by a liquid carbon dioxide batch method, a liquid carbon dioxide reflux method, a supercritical carbon dioxide reflux method, or the like, in addition to the above extraction method.
【0021】また、松樹皮のからの抽出は、複数の抽出
方法を組み合わせてもよい。複数の抽出方法を組み合わ
せることにより、種々の組成の松樹皮抽出物を得ること
が可能となる。The extraction from pine bark may be performed by combining a plurality of extraction methods. By combining a plurality of extraction methods, it becomes possible to obtain pine bark extracts having various compositions.
【0022】本発明に用いられる松樹皮抽出物には、プ
ロアントシアニジンの縮重合体、すなわち、フラバン−
3−オールおよび/またはフラバン−3,4−ジオール
を構成単位とする重合度が2以上の縮重合体が含まれて
いる。縮重合体としては、重合度の低い縮重合体が好ま
しく用いられる。重合度が2〜30の縮合重合体(2〜
30量体)が好ましく、重合度が2〜10の縮合重合体
(2〜10量体)がより好ましく、重合度が2〜4の縮
合重合体(2〜4量体)がさらに好ましく用いられる。The pine bark extract used in the present invention includes a polyanthocyanidin condensation polymer, that is, flavan-
A polycondensate having a degree of polymerization of 2 or more and containing 3-ol and / or flavan-3,4-diol as a constitutional unit is contained. As the polycondensate, a polycondensate having a low degree of polymerization is preferably used. Condensation polymer having a degree of polymerization of 2 to 30 (2 to
30-mer) is preferable, a condensation polymer having a degree of polymerization of 2-10 (2-10-mer) is more preferable, and a condensation polymer having a degree of polymerization of 2-4 (2-4mer) is more preferably used. .
【0023】本明細書では、プロアントシアニジンの縮
重合体のうち、フラバン−3−オールおよび/またはフ
ラバン−3,4−ジオールを構成単位とする重合度が2
〜4の重合体を、OPC(オリゴメリック・プロアント
シアニジン;oligomeric proanthocyanidin)という。In the present specification, among polycondensates of proanthocyanidins, the degree of polymerization of flavan-3-ol and / or flavan-3,4-diol as a constituent unit is 2
The polymers of 4 to 4 are called OPC (oligomeric proanthocyanidin).
【0024】OPCは、ポリフェノールの一種で、植物
が作り出す強力な抗酸化物質であり、植物の葉、樹皮、
果物の皮や種の部分に集中的に含まれている。具体的に
は、ブドウの種、松の樹皮、ピーナッツの皮、イチョ
ウ、ニセアカシアの果実、コケモモなどに含まれてい
る。また、西アフリカのコーラナッツ、ペルーのラタニ
アの根、日本の緑茶にも、OPCが含まれることが知ら
れている。OPCは、ヒトの体内では、生成することの
できない物質である。OPC is a kind of polyphenol, which is a powerful antioxidant produced by plants, such as plant leaves, bark,
It is concentrated in the peels and seeds of fruits. Specifically, it is contained in grape seed, pine bark, peanut skin, ginkgo, black locust fruit, cowberry and the like. It is also known that cola nuts in West Africa, roots of Latania in Peru, and green tea in Japan also contain OPC. OPC is a substance that cannot be produced in the human body.
【0025】このようなOPCは、抗酸化物質であるた
め、ガン・心臓病・脳血栓などの成人病の危険率を低下
する効果、関節炎・アトピー性皮膚炎・花粉症などのア
レルギー体質の改善効果等を有する。Since such OPC is an antioxidant, it has the effect of lowering the risk rate of adult diseases such as cancer, heart disease and cerebral thrombosis, and the effect of improving allergic constitution such as arthritis, atopic dermatitis and hay fever. And so on.
【0026】さらにOPCは、抗酸化作用のほか、口腔
内のバクテリア増殖を抑制してプラーク(歯こう)を減
少させる効果、血管の弾力性を回復させる効果、血液中
でのリポたんぱくが活性酸素によりダメージを受けるの
を防止して、損傷した脂肪が血管の内壁に凝集し、コレ
ステロールが付着することを防止する効果、活性酸素に
よって分解されたビタミンEを再生させる効果、ビタミ
ンEの増強剤としての効果等を有することが知られてい
る。Further, OPC has an antioxidant effect, an effect of suppressing bacterial growth in the oral cavity to reduce plaque (dental plaque), an effect of restoring elasticity of blood vessels, and lipoprotein in blood is a reactive oxygen species. As a potentiator of vitamin E, the effect of preventing damaged fat from aggregating on the inner wall of blood vessels and preventing cholesterol from adhering, regenerating vitamin E decomposed by active oxygen, Is known to have the effect of.
【0027】本発明においては、OPCを20重量%以
上含有する松樹皮抽出物が好ましく用いられる。好まし
くは30重量%以上である。In the present invention, a pine bark extract containing 20% by weight or more of OPC is preferably used. It is preferably 30% by weight or more.
【0028】松樹皮抽出物として、OPCを用いると、
重合度の高いものを用いた場合と対比して、より優れた
皮膚改善効果が得られる。When OPC is used as the pine bark extract,
A more excellent skin improving effect can be obtained as compared with the case of using one having a high degree of polymerization.
【0029】本発明に用いられる松樹皮抽出物は、カテ
キン(catechin)類を、5重量%以上含有することが好
ましい。カテキン類は、松樹皮からも抽出され、松樹皮
抽出物に含まれる。すなわち、カテキン類は、OPCと
ともに抽出され得る。The pine bark extract used in the present invention preferably contains 5% by weight or more of catechins. Catechins are also extracted from pine bark and are included in the pine bark extract. That is, catechins can be extracted together with OPC.
【0030】カテキン類とは、ポリヒドロキシフラバン
−3−オールの総称であり、狭義のカテキンといわれて
いる(+)−カテキンのほか、ガロカテキン、アフゼレ
キン、(+)−カテキンまたはガロカテキンの3−ガロ
イル誘導体が、天然物から単離されている。カテキン類
としては、(+)−カテキン、(−)−エピカテキン、
(+)−ガロカテキン、(−)−エピガロカテキン、エ
ピガロカテキンガレート、エピカテキンガレートなどが
知られている。カテキン類には、発癌抑制、動脈硬化予
防、脂肪代謝異常の抑制、血圧上昇の抑制、血栓予防、
抗アレルギー、抗ウイルス、抗菌、虫歯予防、口臭防
止、腸内細菌叢正常化効果、活性酸素やフリーラジカル
の消去作用、抗酸化作用等があることが知られている。
また、カテキン類には、血糖の上昇を抑制する抗糖尿病
効果があることが知られている。The catechins are a general term for polyhydroxyflavan-3-ols, and in addition to (+)-catechin, which is said to be catechin in a narrow sense, gallocatechin, afzelekin, (+)-catechin or 3-galloyl of gallocatechin. Derivatives have been isolated from natural products. As catechins, (+)-catechin, (-)-epicatechin,
(+)-Gallocatechin, (-)-epigallocatechin, epigallocatechin gallate, epicatechin gallate, etc. are known. For catechins, carcinogenesis suppression, arteriosclerosis prevention, fat metabolism abnormality suppression, blood pressure increase suppression, thrombosis prevention,
It is known to have antiallergic, antiviral, antibacterial, tooth decay prevention, halitosis prevention, intestinal flora normalization effect, active oxygen and free radical scavenging effect, antioxidant effect and the like.
Further, catechins are known to have an antidiabetic effect of suppressing an increase in blood sugar.
【0031】カテキン類は、OPCの存在下で水に溶解
しやすくなると同時に、活性になる性質がある。Catechins have the property that they are easily dissolved in water in the presence of OPC and, at the same time, they become active.
【0032】本発明の皮膚改善剤としては、カテキン類
を5重量%以上含有し、かつOPCを20重量%以上含
有する松樹皮抽出物を用いることが最も好ましい。松樹
皮抽出物のOPC含量が20重量%未満の場合、あるい
はカテキン類含量が5重量%未満の場合、OPC含量が
20重量%以上となるように、あるいはカテキン類含量
が5重量%以上となるように、OPCあるいはカテキン
類を添加してもよい。As the skin improving agent of the present invention, it is most preferable to use a pine bark extract containing 5% by weight or more of catechins and 20% by weight or more of OPC. When the OPC content of the pine bark extract is less than 20% by weight, or the catechins content is less than 5% by weight, the OPC content is 20% by weight or more, or the catechins content is 5% by weight or more. Thus, OPC or catechins may be added.
【0033】本発明の皮膚改善剤に用いられる松樹皮抽
出物は、具体的には、以下のような方法により調製され
るが、これは例示であり、この方法に限定されない。The pine bark extract used for the skin improving agent of the present invention is specifically prepared by the following method, but this is an example and not limited to this method.
【0034】フランス海岸松の樹皮1kgを、塩化ナト
リウムの飽和溶液3Lで、100℃にて30分間、抽出
し、抽出液を得る(抽出工程)。その後、抽出液をろ過
し、得られる不溶物を塩化ナトリウムの飽和溶液500
mlで洗浄し、洗浄液を得る(洗浄工程)。この抽出液
と洗浄液を合わせて、松樹皮の粗抽出液を得る。1 kg of bark of French coastal pine is extracted with 3 L of a saturated sodium chloride solution at 100 ° C. for 30 minutes to obtain an extract (extraction step). Then, the extract is filtered and the resulting insoluble matter is saturated with sodium chloride solution 500.
Wash with ml to obtain a washing solution (washing step). A crude pine bark extract is obtained by combining the extract and the washing solution.
【0035】次いで、この粗抽出液に酢酸エチル250
mlを添加して分液し、酢酸エチル層を回収する酢酸エ
チル層回収工程を5回行う。なお、この酢酸エチル層回
収工程では、酢酸エチル層を、無水硫酸ナトリウム20
0gで脱水、回収する。その後、この酢酸エチル層を濾
過し、濾液を元の5分の1量になるまで減圧濃縮する。
濃縮された酢酸エチル層を2Lのクロロホルムに注ぎ、
攪拌して得られる沈殿物を濾過により回収する。その
後、この沈殿物を酢酸エチル100mlに溶解した後、
再度1Lのクロロホルムに添加して沈殿させる操作を2
回繰り返す洗浄工程を行う。この方法により、2〜4量
体のOPCを20重量%含み、かつカテキン類を5重量
%以上含有する、約5gの松樹皮抽出物が得られる。Then, ethyl acetate 250 was added to the crude extract.
ml is added and liquid-separated, and the ethyl acetate layer recovery step of recovering the ethyl acetate layer is performed 5 times. In this ethyl acetate layer recovery step, the ethyl acetate layer was replaced with anhydrous sodium sulfate 20%.
Dehydrate and collect at 0 g. After that, the ethyl acetate layer is filtered, and the filtrate is concentrated under reduced pressure until it becomes 1/5 of the original volume.
Pour the concentrated ethyl acetate layer into 2 L of chloroform,
The precipitate obtained by stirring is collected by filtration. Then, after dissolving the precipitate in 100 ml of ethyl acetate,
Add again to 1 L of chloroform to perform precipitation.
Repeat the washing process. By this method, about 5 g of a pine bark extract containing 20% by weight of a 2- to 4-meric OPC and 5% by weight or more of catechins can be obtained.
【0036】本発明の皮膚改善剤としての効果を得るに
は、松樹皮抽出物が1日あたり50mg〜2000m
g、好ましくは100mg〜1000mg摂取されるよ
うに、ヒトに投与するとよい。In order to obtain the effect of the skin improving agent of the present invention, the pine bark extract is 50 mg to 2000 m per day.
g, preferably 100 mg to 1000 mg, may be administered to humans.
【0037】本発明の健康食品は松樹皮抽出物を食品に
配合することにより得られる。健康食品中おける松樹皮
抽出物の含量は、上記摂取量を考慮して決定すればよ
い。The health food of the present invention is obtained by incorporating a pine bark extract into a food. The content of the pine bark extract in the health food may be determined in consideration of the above intake amount.
【0038】本発明の健康食品には、松樹皮抽出物の他
に、必要に応じて、賦形剤、増量剤、結合剤、増粘剤、
乳化剤、着色料、香料、食品添加物、調味料などと混合
され得る。例えば、栄養補助剤として、ローヤルゼリ
ー、ビタミン、プロテイン、卵殻カルシウム等のカルシ
ウム、キトサン、レシチン、クロレラ末、アシタバ末、
モロヘイヤ末などが配合され、さらに、ステビア末、抹
茶パウダー、レモンパウダー、はちみつ、還元麦芽糖、
乳糖、糖液、調味料等を加え、味を整えることができ
る。In the health food of the present invention, in addition to the pine bark extract, if necessary, an excipient, a bulking agent, a binder, a thickening agent,
It can be mixed with emulsifiers, colorants, flavors, food additives, seasonings and the like. For example, as a nutritional supplement, royal jelly, vitamins, proteins, calcium such as egg shell calcium, chitosan, lecithin, chlorella powder, ashitaba powder,
Moroheiya powder, etc. are added, and further, stevia powder, matcha powder, lemon powder, honey, reduced maltose,
The taste can be adjusted by adding lactose, sugar solution, seasonings and the like.
【0039】そして、これらは必要に応じて、ハードカ
プセル、ソフトカプセルのようなカプセル剤、錠剤、も
しくは丸剤としてか、または粉末状、顆粒状、飴状など
の形状に成形され得る。If desired, these can be formed into capsules such as hard capsules and soft capsules, tablets or pills, or formed into powder, granules, candy and the like.
【0040】このような健康食品中に、松樹皮抽出物
は、一般には、剤型にもよるが、0.5〜10重量%、
好ましくは1.0〜7.0重量%の範囲で配合される。In such a health food, the pine bark extract is generally 0.5 to 10% by weight, though it depends on the dosage form.
It is preferably compounded in the range of 1.0 to 7.0% by weight.
【0041】そして、本実施形態に係る皮膚改善剤およ
びそれを含有する健康食品は、その形状または好みに応
じて、そのまま飲食しても良いし、あるいは水、お湯、
牛乳などに溶いて飲んでも良いし、成分を浸出させたも
のを飲んでも良い。The skin improving agent and the health food containing the same according to the present embodiment may be eaten or drink as they are, or may be water, hot water,
You can drink it by dissolving it in milk, etc., or you can drink it by leaching the ingredients.
【0042】[0042]
【実施例】以下に実施例を挙げて本発明を説明するが、
本発明がこの実施例により制限されないことはいうまで
もない。The present invention will be described below with reference to examples.
It goes without saying that the invention is not limited by this example.
【0043】(実施例1)L−アスコルビン酸を低濃度
で含有する精製飼料と、上記方法で得られたOPCを2
0重量%かつカテキンを5重量%以上含有する松樹皮抽
出物(以下、単に松樹皮抽出物という)を用いて本発明
の皮膚改善剤の効果を、以下のようにして評価した。(Example 1) Purified feed containing L-ascorbic acid at a low concentration and OPC obtained by the above-mentioned method
The effect of the skin improving agent of the present invention was evaluated as follows using a pine bark extract containing 0% by weight and 5% by weight or more of catechin (hereinafter, simply referred to as pine bark extract).
【0044】3週齢の雄性のモルモット(日本エスエル
シー(株))に1週間、一般の固形飼料(RC4、オリ
エンタル酵母株式会社)を与えて馴化させた後、総無作
為化法により一群7匹ずつ割り当てた。A 3-week-old male guinea pig (Japan SLC, Inc.) was fed with a standard solid feed (RC4, Oriental Yeast Co., Ltd.) for 1 week for acclimation, and then a group of 7 animals was prepared by the total randomization method. Allotted individually.
【0045】L−アスコルビン酸(0.01%重量%)
を含有する精製飼料を準備した。この精製飼料は、コー
ンスターチ(29.49%)、ミルクカゼイン(20.
00%)、アルファルファミール(10.00%)、α
−ポテトスターチ(10.00%)、セルロースパウダ
ー(10.00%)シュークロース(10.00%)、
大豆油(6.00%)、ミネラル混合物(AIN−7
6、3.50%)、ビタミン混合物(AIN−76、
1.00%)、およびアスコルビン酸(0.01%)の
組成からなる。なお、数字はいずれも重量%を意味す
る。L-ascorbic acid (0.01% by weight)
A purified feed containing was prepared. This refined feed is corn starch (29.49%), milk casein (20.
00%), alfalfa meal (10.00%), α
-Potato starch (10.00%), cellulose powder (10.00%) sucrose (10.00%),
Soybean oil (6.00%), mineral mixture (AIN-7
6, 3.50%), vitamin mixture (AIN-76,
1.00%) and ascorbic acid (0.01%). All the numbers mean% by weight.
【0046】次いで、この精製飼料に、松樹皮抽出物を
0.5%(試験例1)および2.5%(試験例2)とな
るように、それぞれ混合して成型した固形飼料を28日
間、自由摂取させた。Then, the purified feed was mixed with the pine bark extract so as to be 0.5% (Test Example 1) and 2.5% (Test Example 2), and the solid feed was molded for 28 days. , Allowed free intake.
【0047】そして投与28日後、被験動物の背部皮膚
中央部を剥離・摘出した。60℃にて一晩乾燥させた
後、この皮膚を粉砕し、その50mgを5mlの塩酸
(6mol/L)に添加し、ヒーティングブロックを用
いて110℃にて24時間、加熱して加水分解した。次
いで、この加水分解物を試料として、クロラミンT法に
よりヒドロキシプロリン(Hyp)含量を測定した。ヒ
ドロキシプロリンは、コラーゲンに多く含まれており、
ヒドロキシプロリン含量が高ければ、コラーゲンが生成
されていることを示す指標となる。結果を図1に示す。
なお、図1中、対照とあるのは、松樹皮抽出物を含有し
ない精製飼料を与えた群である。28 days after administration, the central part of the back skin of the test animal was peeled off and excised. After drying overnight at 60 ° C., this skin was crushed, 50 mg of it was added to 5 ml of hydrochloric acid (6 mol / L), and heated at 110 ° C. for 24 hours using a heating block for hydrolysis. did. Then, using this hydrolyzate as a sample, the hydroxyproline (Hyp) content was measured by the chloramine T method. Hydroxyproline is abundant in collagen,
A high hydroxyproline content is an indicator that collagen is being produced. The results are shown in Fig. 1.
The control in FIG. 1 is a group fed with a purified feed containing no pine bark extract.
【0048】図1の結果は、松樹皮抽出物を含有する本
発明の皮膚改善剤が、皮膚のコラーゲン含量を増加させ
たことを示しており、皮膚改善剤として有用であること
を示す。The results shown in FIG. 1 show that the skin improving agent of the present invention containing the pine bark extract increased the collagen content of the skin, indicating that it is useful as a skin improving agent.
【0049】また、摘出した背部皮膚は、その一部を1
0%中性緩衝ホルマリンで固定した後、常法に従い、パ
ラフィン切片を作成し、Azan染色を行った。青く染
色されたコラーゲン線維を指標として真皮(コラーゲン
線維)層の厚みをマイクロメータで計測したところ、松
樹皮抽出物を添加した飼料を与えた試験例1および2の
真皮層は、対照群に比べて明らかに厚かった(データ示
さず)。Also, part of the extracted back skin is 1
After fixing with 0% neutral buffered formalin, paraffin sections were prepared according to a conventional method and stained with Azan. When the thickness of the dermis (collagen fiber) layer was measured with a micrometer using the collagen fiber stained in blue as an index, the dermis layer of Test Examples 1 and 2 fed with the feed containing the pine bark extract was compared to the control group. Was clearly thick (data not shown).
【0050】(実施例2)アスコルビン酸を全く含まな
い代わりに、コーンスターチ濃度が29.50%である
精製飼料を用いて、実施例1と同様にして3週齢の雄性
のモルモットを飼育した。28日間飼育した後、コラー
ゲン層の厚みを調べたところ、松樹皮抽出物を添加した
群では、添加しなかった群に比べて明かに厚かった(デ
ータ示さず)。Example 2 A 3-week-old male guinea pig was bred in the same manner as in Example 1 except that it contained no ascorbic acid at all and a purified feed having a corn starch concentration of 29.50% was used. When the thickness of the collagen layer was examined after breeding for 28 days, it was clearly thicker in the group to which the pine bark extract was added than in the group to which no pine bark extract was added (data not shown).
【0051】[0051]
【発明の効果】以上のように、OPCを20重量%以上
かつカテキン類を5重量%以上含有する松樹皮抽出物を
含有することを特徴とする皮膚改善剤を用いれば、皮膚
のコラーゲン含量を増加させ、皮膚を改善できる。Industrial Applicability As described above, the use of a skin improving agent characterized by containing a pine bark extract containing OPC in an amount of 20% by weight or more and catechins in an amount of 5% by weight or more makes it possible to improve the skin collagen content. Can increase and improve the skin.
【図1】図1は、本発明の皮膚改善剤で処理したモルモ
ット皮膚および処理しなかったモルモット皮膚のヒドロ
キシプロリン含量を示す図である。FIG. 1 is a graph showing the hydroxyproline content of guinea pig skin treated with the skin improving agent of the present invention and guinea pig skin not treated.
───────────────────────────────────────────────────── フロントページの続き Fターム(参考) 4B018 MD07 MD09 MD25 MD60 MD61 ME14 MF01 4C086 AA01 AA02 BA03 BA08 MA02 MA03 MA04 NA05 NA14 ZA89 4C088 AB03 AC06 BA08 CA03 MA02 MA03 MA52 MA63 ZA89 ─────────────────────────────────────────────────── ─── Continued front page F-term (reference) 4B018 MD07 MD09 MD25 MD60 MD61 ME14 MF01 4C086 AA01 AA02 BA03 BA08 MA02 MA03 MA04 NA05 NA14 ZA89 4C088 AB03 AC06 BA08 CA03 MA02 MA03 MA52 MA63 ZA89
Claims (5)
る、皮膚改善剤。1. A skin improving agent, comprising a pine bark extract.
ic proanthocyanidin)を20重量%以上含有する松樹
皮抽出物である、請求項1に記載の皮膚改善剤。2. The pine bark extract is an OPC (oligomer).
The skin improving agent according to claim 1, which is a pine bark extract containing 20% by weight or more of ic proanthocyanidin).
(catechin)類を5.0重量%以上含有する松樹皮抽出
物である、請求項2に記載の皮膚改善剤。3. The skin improving agent according to claim 2, wherein the pine bark extract is a pine bark extract further containing 5.0% by weight or more of catechins.
有する、請求項1から3のいずれかの項に記載の皮膚改
善剤。4. The skin improving agent according to any one of claims 1 to 3, further comprising ascorbic acid or a salt thereof.
皮膚改善剤を含有する、健康食品。5. A health food containing the skin improving agent according to any one of claims 1 to 4.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001345277A JP2003146899A (en) | 2001-11-09 | 2001-11-09 | Skin-improving agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001345277A JP2003146899A (en) | 2001-11-09 | 2001-11-09 | Skin-improving agent |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2003146899A true JP2003146899A (en) | 2003-05-21 |
Family
ID=19158642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2001345277A Pending JP2003146899A (en) | 2001-11-09 | 2001-11-09 | Skin-improving agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2003146899A (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005060338A (en) * | 2003-08-19 | 2005-03-10 | Toyo Shinyaku:Kk | Proanthocyanidin-including composition |
JP2005213148A (en) * | 2004-01-27 | 2005-08-11 | Mitsuyo Kanda | Therapeutic agent for skin disease |
JP2005232153A (en) * | 2004-01-21 | 2005-09-02 | Toyo Shinyaku:Kk | Absorption enhancer of bark extract component containing sphingolipid as active ingredient |
KR100580070B1 (en) | 2004-07-07 | 2006-05-16 | 주식회사 엘지생활건강 | Food composition for skin whitening |
WO2006059395A1 (en) * | 2004-12-01 | 2006-06-08 | Toyo Shinyaku Co., Ltd. | External-use skin preparation for enhancing collagen production |
WO2007010911A1 (en) * | 2005-07-15 | 2007-01-25 | Toyo Shinyaku Co., Ltd. | Agent for relieving wound and promoting wound recovery |
FR2939040A1 (en) * | 2008-12-03 | 2010-06-04 | Inneov Snc Lab | ASSOCIATION OF LYCOPENE, POLYPHENOL AND VITAMINS FOR THE CARE OF KERATINIC MATTER |
JP2013241394A (en) * | 2012-04-25 | 2013-12-05 | Kobayashi Pharmaceutical Co Ltd | Agent for increasing water content of skin |
JP2015221759A (en) * | 2014-05-22 | 2015-12-10 | 株式会社東洋新薬 | Collagen synthetic promoter, hyaluronic acid synthetic promoter, and ceramide synthetic promoter |
WO2024171994A1 (en) * | 2023-02-14 | 2024-08-22 | 株式会社東洋新薬 | Composition, composition for inhibiting platelet aggregation, composition for ameliorating hypertension, and composition for improving skin texture |
-
2001
- 2001-11-09 JP JP2001345277A patent/JP2003146899A/en active Pending
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005060338A (en) * | 2003-08-19 | 2005-03-10 | Toyo Shinyaku:Kk | Proanthocyanidin-including composition |
JP2005232153A (en) * | 2004-01-21 | 2005-09-02 | Toyo Shinyaku:Kk | Absorption enhancer of bark extract component containing sphingolipid as active ingredient |
JP2005213148A (en) * | 2004-01-27 | 2005-08-11 | Mitsuyo Kanda | Therapeutic agent for skin disease |
KR100580070B1 (en) | 2004-07-07 | 2006-05-16 | 주식회사 엘지생활건강 | Food composition for skin whitening |
WO2006059395A1 (en) * | 2004-12-01 | 2006-06-08 | Toyo Shinyaku Co., Ltd. | External-use skin preparation for enhancing collagen production |
WO2007010911A1 (en) * | 2005-07-15 | 2007-01-25 | Toyo Shinyaku Co., Ltd. | Agent for relieving wound and promoting wound recovery |
FR2939040A1 (en) * | 2008-12-03 | 2010-06-04 | Inneov Snc Lab | ASSOCIATION OF LYCOPENE, POLYPHENOL AND VITAMINS FOR THE CARE OF KERATINIC MATTER |
WO2010064210A1 (en) * | 2008-12-03 | 2010-06-10 | Laboratoires Inneov Snc | Combination of lycopene, polyphenol, and vitamins for the care of keratin material |
RU2517132C2 (en) * | 2008-12-03 | 2014-05-27 | Лаборатуар Иннеов Снс | Combination of lycopene, polyphenol and vitamins for care of keratin materials |
US9000049B2 (en) | 2008-12-03 | 2015-04-07 | Laboratories Inneov SNC | Combination of lycopene, polyphenol, and vitamins for the care of keratin materials |
JP2013241394A (en) * | 2012-04-25 | 2013-12-05 | Kobayashi Pharmaceutical Co Ltd | Agent for increasing water content of skin |
JP2015221759A (en) * | 2014-05-22 | 2015-12-10 | 株式会社東洋新薬 | Collagen synthetic promoter, hyaluronic acid synthetic promoter, and ceramide synthetic promoter |
WO2024171994A1 (en) * | 2023-02-14 | 2024-08-22 | 株式会社東洋新薬 | Composition, composition for inhibiting platelet aggregation, composition for ameliorating hypertension, and composition for improving skin texture |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110159128A1 (en) | Alcohol metabolism enhancer and alcoholic beverage | |
JP2003325135A (en) | Health food | |
JP2003146898A (en) | Hyperlipemia-improving agent | |
JP2005029486A (en) | Skin-improving composition | |
JP2004123707A (en) | Blood circulation-ameliorating composition | |
US9132159B2 (en) | Composition for prevention and/or treatment of tumors containing acacia derivative | |
JP2003146899A (en) | Skin-improving agent | |
JP2005097273A (en) | Athletic ability-enhancing composition | |
JP2010159283A (en) | Proanthocyanidin-containing composition | |
JP3556659B1 (en) | Food composition | |
JP2003334022A (en) | Endurance-improving food composition | |
JP3689413B2 (en) | Flavan compound-containing composition | |
JP2004049135A (en) | Health food | |
JP2003325136A (en) | Arthritis-improving food | |
JP2003095965A (en) | Hypertension-preventing and treating medicine | |
JP2003095964A (en) | Anti-stress medicine | |
JP2003238426A (en) | Collagenase inhibitor, skin external agent and health food | |
JP2005237291A (en) | Health food | |
JP2005047839A (en) | Proanthocyanidin-containing composition | |
JP4400712B2 (en) | Antioxidant enhancement food | |
JP2005060338A (en) | Proanthocyanidin-including composition | |
JP2004210675A (en) | Bone quantity amelioration composition | |
JP4754190B2 (en) | Alcohol metabolism improver | |
JP5681895B2 (en) | Food composition | |
JP4504118B2 (en) | Alcoholic beverage |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060404 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060529 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20060529 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20060627 |